Allspring Global Investments Holdings LLC Increases Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Allspring Global Investments Holdings LLC has sold its interest in Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) increased 30.7% during the fourth quarter, according to its latest filing with the Securities & Exchange Commission. The company owned 8,214 shares of the company, after purchasing an additional 1,928 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Privia Health Group were worth $189,000 at the time of the most recent SEC filing.

Other major investors have also changed their holdings in the company. Covestor Ltd increased its position in Privia Health Group by 8.3% in the third quarter. Covestor Ltd now owns 6,703 shares of the company’s stock valued at $154,000 after purchasing an additional 514 shares in the last quarter. Yousif Capital Management LLC increased its holdings in shares of Privia Health Group by 1.1% in the third quarter. Yousif Capital Management LLC now owns 52,065 shares of the company’s stock worth $1,197,000 after acquiring an additional 574 shares during the last quarter. The New York State Common Retirement Fund increased its position in shares of Privia Health Group by 2.7% in the third quarter. New York State Common Retirement Fund now owns 27,966 shares of the company’s stock worth $643,000 after purchasing an additional 737 shares during the period. Glenmede Trust Co. NA increased its stake in Privia Health Group by 0.9% in the third quarter. Glenmede Trust Co. NA now owns 107,711 shares of the company’s stock valued at $2,477,000 after purchasing an additional 976 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund increased its position in Privia Health Group by 3.8% in the third quarter. Oregon Public Employees Retirement Fund now owns 30,300 shares of the company’s stock valued at $697,000 after purchasing an additional 1,100 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s shares.

Privia Health Group is trading 1.5% higher

Shares of PRVA stock opened at $18.26 on Friday. The company has a market cap of $2.17 billion, a price-to-earnings ratio of 96.11, a PEG ratio of 2.46, and a beta of 0.81. The company has a fifty-day moving average of $19.81 and a 200-day moving average of $21.23. Privia Health Group, Inc. has a 12-month low of $17.54 and a 12-month high of $30.15.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last announced its quarterly results on Tuesday, February 27. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. The company had revenue of $440.80 million for the quarter, compared to analyst expectations of $425.81 million. During the same period last year, the company earned $0.14 earnings per share. The company’s quarterly revenue increased 21.0% year over year. On average, stock analysts predict that Privia Health Group, Inc. will post a profit per share of 0.26 for the current year.

Buy and sell Insider at Privia Health Group

In other Privia Health Group news, CFO David Mountcastle sold 3,933 shares of Privia Health Group stock in a transaction that took place on Tuesday, April 2nd. The stock sold at an average price of $17.77, for a total transaction of $69,889.41. Following the transaction, the chief financial officer now owns 262,279 shares of the company’s stock, valued at $4,660,697.83. The transaction was disclosed in a filing with the SEC, which is available at this link. 14.20% of the shares are currently owned by insiders.

Analyst upgrades and downgrades

A number of stock analysts have recently weighed in on the company. Evercore ISI lowered their price objective on Privia Health Group from $26.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28. Barclays initiated coverage on shares of Privia Health Group in a research note on Wednesday, March 6. They set an equalweight rating and a $22.00 price target for the stock. JPMorgan Chase & Co. lowered their target price on shares of Privia Health Group from $38.00 to $30.00 in a research note on Wednesday, March 6. Canaccord Genuity Group lowered their target price on shares of Privia Health Group from $41.00 to $37.00 and set a “buy” rating on the stock in a research note on Tuesday, March 19. Finally, UBS Group lowered their price target on shares of Privia Health Group from $31.00 to $29.00 and set a “buy” rating on the company in a research report on Friday, March 1st. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $27.92.

Check out our latest report on PRVA

Privia Health Group Profile

(Free report)

Privia Health Group, Inc operates as a national physician support company in the United States. The company partners with medical groups, health plans and healthcare systems to optimize physician practices, improve patient experiences and reward physicians for delivering care in in-person and virtual environments.

Privia Health Group is trading 1.5% higher

Buy and sell Insider at Privia Health Group

Analyst upgrades and downgrades

Privia Health Group Profile

Recommended articles

Related Posts